首页> 外国专利> new composition for transdermal and / or transmukosalen wirkstoffanwendung with suitable therapeutic levels

new composition for transdermal and / or transmukosalen wirkstoffanwendung with suitable therapeutic levels

机译:具有适当治疗水平的用于透皮和/或透皮细胞的新组合物

摘要

The present invention refers to a pharmaceutical composition suitable for the transdermal or transmucosal administration of one or more active agents, in form of a gel or a solution, comprising as a permeation enhancers a combination of: a) saturated fatty alcohol of formula CH3-(CH2)n-CH2OH or saturated fatty acid CH3-(CH2)n-CH2COOH wherein n is an integer number 8 + 22, preferably 8 + 12, most preferably 10, or unsaturated fatty alcohol or fatty acid of formula: CH3(CnH2(n-1))-OH or CH3(CnH2(n-1))-COOH wherein n is an integer number 8 + 22, b) a ternary vehicle or carrier consisting of a C1 + C4 alkanol, a polyalcohol in particular propylenglycol and water, c) optionally also a monoalkylether of diethylenglycol.
机译:本发明涉及适于以凝胶或溶液形式透皮或透粘膜施用一种或多种活性剂的药物组合物,其包含作为渗透增强剂的组合:a)式CH 3-的饱和脂肪醇CH2)n-CH2OH或饱和脂肪酸CH3-(CH2)n-CH2COOH,其中n为8 + 22,优选8 + 12,最优选10的整数,或不饱和脂肪醇或式CH3(CnH2( n-1))-OH或CH3(CnH2(n-1))-COOH,其中n为8 + 22的整数,b)由C1 + C4链烷醇,多元醇(尤其是丙二醇)和c)任选地还为二乙二醇的单烷基醚。

著录项

  • 公开/公告号DE60127134D1

    专利类型

  • 公开/公告日2007-04-19

    原文格式PDF

  • 申请/专利权人 ANTARES PHARMA IPL AG;

    申请/专利号DE2001627134T

  • 申请日2001-08-03

  • 分类号A61K47/08;A61K47/10;A61K9/00;A61K9/06;A61K9/08;A61K45/00;A61K47/12;A61K47/32;A61K47/34;A61K47/36;A61K47/38;A61K47/46;

  • 国家 DE

  • 入库时间 2022-08-21 20:28:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号